Aspen Pharmacare expects African sales of Eli Lilly's blockbuster weight-loss and diabetes drug Mounjaro to exceed 2 ‌billion rand ($124 million) in its current financial year, buoyed by surging ...

The FDA has approved Mounjaro to reduce cardiovascular risk in people with type 2 diabetes after a major trial found it ...

For decades, type 2 diabetes was managed with medicines that either pushed insulin higher or improved how the body used it.

Eli Lilly said on Friday the U.S. FDA has approved ​its diabetes drug Mounjaro to reduce the chances of heart ‌attack or ...

Mounjaro is the first and only GIP and GLP-1 receptor agonist proven to lower heart attack, stroke or cardiovascular death risk in adults with type 2 diabetes at high risk for these events – in ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

Some viruses can be specially changed to infect and kill cancer cells while leaving healthy cells alone. These viruses can also activate the immune system, helping it recognize and attack other cancer ...

Weight-loss drugs, peptides, I.V.F. As sharps migrate out of doctors’ offices, even needle-phobics are willing to embrace shots. Credit...By Timo Lenzen Supported by By Liz Krieger Conz Preti ...